Integra LifeSciences (NSDQ:IART) shares ticked up in pre-market trading today after the medical device company reported third-quarter numbers that topped estimates. Plainsboro, N.J.-based Integra posted losses of -27.6 million, or -32¢ per share, on sales of $379.1 million for the three months ended Sept. 30, marking a swing to red ink on sales growth of […]
Integra Lifesciences touts Cadence ankle study
Integra LifeSciences (NSDQ:IART) yesterday touted positive findings from its Cadence total ankle system retrospective study and closed enrollment ahead of schedule for two post-market studies of the device. The study reported that patients treated with Cadence while suffering from end-stage arthritis experienced improvements in quality of life, functional measures and pain. The results were presented during […]
Integra LifeSciences buys Rebound Therapeutics
Integra LifeSciences (NSDQ:IART) said today that it has acquired Rebound Therapeutics, maker of a single-use, minimally invasive neurosurgery device. Financial terms of the deal were not disclosed. Rebound touts its Aurora Surgiscope system, — cleared by FDA in January — as the first single-use disposable neurosurgical endoscope. The Aurora system enables minimally invasive access, visualization and […]
Integra Lifesciences picks up Arkis Biosciences
Integra LifeSciences (NSDQ:IART) this week acquired Arkis BioSciences and its line of neurosurgery devices for an undisclosed amount. Knoxville, Tenn.-based Arkis makes the CerebroFlo external ventricular drainage catheter that uses its Endexo anti-thrombus additive to prevent blood clots. “Neurocritical care is an important area of focus for Integra. We recently introduced our CereLink intracranial pressure monitor […]
Integra LifeSciences tops Q2 consensus, raises earnings outlook
Integra LifeSciences (NSDQ:IART) today reported second-quarter results that beat the consensus estimate for both sales and earnings and raised its earnings outlook for the rest of the year. The Plainsboro, N.J.-based medical device company said profits rose 161.4% to $29.7 million, or 34¢ per share, on sales growth of 4.8% to $383.6 million compared with […]
Integra Lifesciences ticks up on Q1 earnings beat
Integra LifeSciences (NSDQ:IART) shares ticked up today in pre-market activity after the medical device company reported first-quarter earnings that beat the consensus forecast. Plainsboro, N.J.-based Integra posted profits of $32.8 million, or 38¢ per share, on sales of $359.7 million for the three months ended March 31, for bottom-line growth of 198.0% on flat sales […]
FDA warns Integra’s TEI Biosciences over quality, validation issues
The FDA recently revealed a warning letter it sent to Integra LifeSciences‘ (NSDQ:IART) TEI Biosciences over four noted violations it found during an inspection of TEI’s Boston-based facilities. The federal watchdog said that it inspected the company’s facilities where it produces collagen-based medical devices, including its Xenform soft tissue repair matrix, from last October to […]
Integra LifeSciences reveals FDA warning letter over chronic wound treatment
Integra LifeSciences (NSDQ:IART) today revealed its receipt of a warning letter sent by the FDA last week about quality system issues at a Boston-area plant that makes products to treat chronic wounds. Plainsboro, N.J.-based Integra said the FDA inspected the plant last October and November, resulting in a Form 483 covering the problems found there. […]
JenaValve names Kilcoyne as CEO | Personnel Moves – January 15, 2019
JenaValve Technology said today that it named former ReVision Optics prez & CEO John Kilcoyne as its new chief executive officer, effective immediately, replacing Dr. Victoria Carr-Brendell, who has taken up an executive leadership position with Sonova Holding AG (SIX:SOON). Prior to his time at ReVision Optics, Kilcoyne served as prez & CEO at Micrus Endovascular where he […]
Boston Scientific shares tick up after Q4 prelims meet estimates | Wall Street Beat
Shares in Boston Scientific (NYSE:BSX) rose slightly this morning after the company reported preliminary results for the fourth quarter and full year of 2018 that were in-line with estimates on Wall Street. The Marlborough, Mass.-based company said it expects to report $2.56 billion in sales for the fourth quarter and $9.82 billion for the full year. […]
Google taps ex-Geisinger CEO Feinberg to lead consolidated Google Health biz | Personnel Moves – November 14, 2018
Google (NSDQ:GOOG) has picked up former Geisinger Health CEO David Feinberg to lead its fragmented health divisions under the Google Health moniker, according to a recent CNBC report. The tech giant had been searching for a head for several months, with artificial intelligence head Jeff Dean heavily involved in the process, according to the report. Other […]
- 1
- 2
- 3
- …
- 9
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube